About: Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD
Creator	Uchida, Yoshitaka Sato, Hiroki Tanaka, Akihiko Homma, Tetsuya Kishino, Yasunari Kusumoto, Sojiro Sagara, Hironori Sato, Yoko Goto, Onitsuka Goto, Yuiko Hirai, Kuniaki Ikeda, Hitoshi Inoue, Hideki Jinno, Megumi Kawahara, Tomoko Kimura, Tomoyuki Mikuni, Hatsuko Miyata, Yoshito Ohta, Shin Onitsuka, Chisato Sato, Haruna Suzuki, Shintaro Tokimatsu, Issei Uno, Tomoki Watanabe, Yoshio Yamamoto, Mayumi
Source	Elsevier; PMC
abstract	Use of systemic corticosteroids for the treatment for coronavirus disease 2019 (COVID-19) among chronic obstructive pulmonary disease (COPD) patients is not well described. A 58-year-old man with fever and progressive dyspnea was admitted to the Showa University Hospital, and showed severe respiratory failure which needed mechanical ventilation. His chest computed tomography scanning showed emphysema and bilateral ground-glass opacity caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. He received 30 mg prednisolone for five days with antiviral drug of favipiravir, and was successfully extubated on day five. A SARS-CoV-2 polymerase chain reaction (PCR) test became negative on day 15. He was discharged on day 21. Serum IgM and IgG antibodies against SARS-CoV-2 converted to positive on day 7 and they kept positive on day 54 for both IgM and IgG. Combination treatment of short-course systemic corticosteroid and favipiravir might improve the prognosis for critically ill COVID-19 pneumonia with COPD without negative influence on viral clearance or antibody production.
has issue date	2020-08-27(xsd:dateTime)
bibo:doi	10.1016/j.rmcr.2020.101200
has license	no-cc
sha1sum (hex)	ca597de8e5fcb659efe80378f94c96667011bb6b
schema:url	https://doi.org/10.1016/j.rmcr.2020.101200
resource representing a document's title	Combination treatment of short-course systemic corticosteroid and favipiravir in a successfully treated case of critically ill COVID-19 pneumonia with COPD
has PubMed Central identifier	PMC7450252
schema:publication	Respir Med Case Rep
resource representing a document's body	covid:ca597de8e5fcb659efe80378f94c96667011bb6b#body_text
is schema:about of	named entity 'corticosteroid' named entity 'SARS-CoV-2' named entity 'patient' named entity 'effective' named entity 'Conflicts' named entity 'efficacy' named entity 'pneumonia' named entity 'case' named entity 'seropositivity' named entity 'The' named entity 'negative' named entity 'Conclusion' named entity 'favipiravir' named entity 'Interest' named entity 'corticosteroid' named entity 'These' named entity 'Sagara' named entity 'future studies' named entity 'COVID-19' named entity 'supervision' named entity 'severe' named entity 'corticosteroid' named entity 'negative' named entity 'test' named entity 'treated' named entity 'SARS-CoV-2' named entity 'corticosteroid' named entity 'SARS-CoV-2' named entity 'doi' named entity 'COPD' named entity 'pneumonia' named entity 'favipiravir' named entity 'seroconversion' named entity 'coronavirus disease 2019' named entity 'COI' named entity 'infection' named entity 'COPD' named entity 'COPD' named entity 'corticosteroid' named entity 'critically ill' named entity 'favipiravir' named entity 'heparin' named entity 'COPD' named entity 'COVID' named entity 'Serum' named entity 'edoxaban' named entity 'COVID' named entity 'deep vein thrombosis' named entity 'continuous infusion' named entity 'nasal swab' named entity 'fever' named entity 'clinical trial' named entity 'prognosis' named entity 'critically ill' named entity 'contrast-enhanced CT' named entity 'severe respiratory failure' named entity 'tazobactam' named entity 'favipiravir'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software